PhRMA to Revive Medicare Drug Price Lawsuit Before Fifth Circuit

A health provider trade association, a patient advocacy group, and a top drug lobby will attempt to restore their case against a government drug price-setting program before a federal appeals court Wednesday.

Attorneys for the National Infusion Center Association, the Global Colon Cancer Association, and the Pharmaceutical Research and Manufacturers of America will take to the US Court of Appeals for the Fifth Circuit to argue their case against the Biden administration’s Medicare Drug Price Negotiation Program.

At issue is whether the groups’ claims arise under a certain Medicare statute and if they have ...